Featured Research

from universities, journals, and other organizations

The girl who couldn't stop laughing

Date:
June 15, 2014
Source:
ecancer
Summary:
A six-year-old Bolivian girl presented with an unusual medical symptom: uncontrollable and inappropriate fits of laughter. “She was considered spoiled, crazy, even devil-possessed,” according to those who knew her. Then medical researchers discovered a hamartoma -- a small tumor pressing on the temporal lobe of her brain.

A six-year-old Bolivian girl presented with an unusual medical symptom: uncontrollable and inappropriate fits of laughter. "She was considered spoiled, crazy, even devil-possessed," says Dr José Liders Burgos Zuleta. Doctors diagnosed the child with "misbehaviour."

In a new research paper published in ecancermedicalscience, Dr Liders Burgos successfully diagnosed the true cause of the little girl's gelastic, or laughing, seizures. Unable to perform a biopsy, his team turned to imaging to examine the girl's brain.

They discovered a hamartoma -- a small tumour pressing on the temporal lobe of her brain.

Dr Liders Burgos hopes that this will assist other Latin American doctors in diagnosing the true cause of behavioural issues in children. "This case is interesting because these Latin American children will be referred to a neurologist," he says.

After surgery, the young girl is now healthy and developing normally. She has not suffered further seizures -- and now only laughs for normal reasons.


Story Source:

The above story is based on materials provided by ecancer. Note: Materials may be edited for content and length.


Journal Reference:

  1. José Liders Burgos Zuleta, Roger Carillo Mezo, Eduardo Perusquia Ortega, Beatriz Luna Barrón, Rubén Conde Espinosa, Diana P Marín Muentes, Julián Sánchez Cortázar, María de Guadalupe Gómez Pérez, José Alvaro Burgos Zuleta and José Andres Burgos Zuleta. Child with temporal lobe hamartoma: A to Z images and a case report. eCancer, 2014 DOI: 10.3332/ecancer.2014.436

Cite This Page:

ecancer. "The girl who couldn't stop laughing." ScienceDaily. ScienceDaily, 15 June 2014. <www.sciencedaily.com/releases/2014/06/140615143612.htm>.
ecancer. (2014, June 15). The girl who couldn't stop laughing. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2014/06/140615143612.htm
ecancer. "The girl who couldn't stop laughing." ScienceDaily. www.sciencedaily.com/releases/2014/06/140615143612.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins